Zhang Lei portfolio, Q1 2025
HHLR Advisors (Hillhouse) · 13F for the quarter ending Mar 31, 2025
For Q1 2025, HHLR Advisors (Hillhouse) reported $3.5B across 49 US-listed positions, led by PDD (21.9%), BABA (14.6%) and FUTU (12.5%). Compared with its filing for Q4 2024, Zhang Lei opened 11 new positions, added to 8, reduced 10 and sold out of 7; 20 positions did not change.
The largest purchase was an addition to PDD ($453.6M); the largest sale, a reduction of ONC ($753.9M).
Key facts
- 13F portfolio value
- $3.5BQ1 2025
- Positions
- 49
- Largest holding
- PDD 21.9%
- New positions
- 11
- Sold out
- 7
- Filed
- May 15, 2025
Holdings as of (Q1 2025), filed with the SEC on . Changes are measured against the filing for Dec 31, 2024. Every tracked investor's Q1 2025 13F.
Bought and sold in Q1 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| Beone Medicines LtdONC | ▼ Reduced 73% | −2.77M | $753.9M | 21.3% |
| PDD Holdings IncPDD | ▲ Added 140% | +3.83M | $453.6M | 12.8% |
| Futu Holdings LtdFUTU | ▲ Added 285% | +3.19M | $326.4M | 9.22% |
| Alibaba Group Holding LtdBABA | ▼ Reduced 20% | −979.55K | $129.5M | 3.66% |
| Vipshop Holdings LtdVIPS | ▼ Reduced 55% | −8.2M | $128.5M | 3.63% |
| JD.com IncJD | ▲ Added 185% | +3.12M | $128.4M | 3.63% |
| Kiniksa Pharmaceuticals InternationalKNSA | ▼ Sold out | −1.58M | $31.3M | 0.88% |
| Bridgebio Pharma IncBBIO | ▼ Sold out | −1.02M | $28.1M | 0.79% |
| Baidu IncBIDU | ▲ New | +170K | $15.6M | 0.44% |
| LI Auto IncLI | ▲ New | +620K | $15.6M | 0.44% |
| Yum China Holdings IncYUMC | ▲ New | +292.12K | $15.2M | 0.43% |
| KE Holdings IncBEKE | ▲ Added 6.3% | +712.13K | $14.3M | 0.40% |
| Kanzhun LimitedBZ | ▲ New | +576.34K | $11M | 0.31% |
| H World Group LtdHTHT | ▲ New | +237.33K | $8.8M | 0.25% |
| NetEase IncNTES | ▲ Added 3.1% | +79.75K | $8.2M | 0.23% |
| Atour Lifestyle Holdings LtdATAT | ▲ New | +242.34K | $6.9M | 0.19% |
| Maze Therapeutics IncMAZE | ▲ New | +457.54K | $5M | 0.14% |
| Zto Express Cayman IncZTO | ▲ Added 54% | +235.46K | $4.7M | 0.13% |
| Sohu.com LtdSOHU | ▼ Reduced 61% | −309.05K | $4.1M | 0.11% |
| GE Vernova IncGEV | ▼ Sold out | −7.83K | $2.6M | 0.07% |
| Taiwan Semiconductor Manufacturing Company LtdTSM | ▼ Reduced 23% | −9.59K | $1.6M | 0.04% |
| Trip.com Group LtdTCOM | ▲ Added 2.7% | +25K | $1.6M | 0.04% |
| China Yuchai International LtdCYD | ▲ New | +70K | $1.2M | 0.03% |
| Danaher CorpDHR | ▼ Reduced 39% | −5.05K | $1M | 0.03% |
| Weibo CorpWB | ▲ New | +100K | $947K | 0.03% |
| Trane Technologies PLCTT | ▼ Sold out | −2.34K | $863.5K | 0.02% |
| MSCI IncMSCI | ▼ Reduced 42% | −1.52K | $860.7K | 0.02% |
| Moodys CorpMCO | ▼ Reduced 41% | −1.84K | $856.9K | 0.02% |
| Metagenomi IncMGX | ▼ Reduced 81% | −627.07K | $852.8K | 0.02% |
Dada Nexus Ltdno ticker on file | ▼ Sold out | −700K | $847K | 0.02% |
| X FinancialXYF | ▲ New | +50K | $719.5K | 0.02% |
| GE AerospaceGE | ▼ Reduced 35% | −3.57K | $714.7K | 0.02% |
| Pyxis Oncology IncPYXS | ▼ Sold out | −382.61K | $596.9K | 0.02% |
| Ecarx Holdings IncECX | ▲ New | +400K | $504K | 0.01% |
| Hello Group IncMOMO | ▼ Sold out | −53.59K | $413.2K | 0.01% |
| JOYY IncJOYY | ▲ Added 13% | +4K | $167.9K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| 1 | PDD Holdings IncPDD · SPONSORED ADS | Consumer Discretionary | 21.9% | $776.7M | 6.56M | $118.35 | 4+ qtrs | ▲ Added 140% |
| 2 | Alibaba Group Holding LtdBABA · SPONSORED ADS | Consumer Discretionary | 14.6% | $516.7M | 3.91M | $132.23 | 4+ qtrs | ▼ Reduced 20% |
| 3 | Futu Holdings LtdFUTU · SPON ADS CL A | Financials | 12.5% | $440.9M | 4.31M | $102.35 | 4+ qtrs | ▲ Added 285% |
| 4 | Beone Medicines LtdONC · SPONSORED ADS | Health Care | 7.95% | $281.5M | 1.03M | $272.17 | 4+ qtrs | ▼ Reduced 73% |
| 5 | NetEase IncNTES · SPONSORED ADS | Technology | 7.76% | $274.7M | 2.67M | $102.92 | 4+ qtrs | ▲ Added 3.1% |
| 6 | KE Holdings IncBEKE · SPONSORED ADS | Real Estate | 6.80% | $240.5M | 11.97M | $20.09 | 4+ qtrs | ▲ Added 6.3% |
| 7 | Legend Biotech CorpLEGN · SPONSORED ADS | Health Care | 5.74% | $203.1M | 5.98M | $33.93 | 4+ qtrs | No change |
| 8 | JD.com IncJD · SPON ADS CL A | Consumer Discretionary | 5.59% | $197.9M | 4.81M | $41.12 | 4+ qtrs | ▲ Added 185% |
| 9 | Vipshop Holdings LtdVIPS · SPONSORED ADS A | Consumer Discretionary | 2.96% | $104.8M | 6.68M | $15.68 | 4+ qtrs | ▼ Reduced 55% |
| 10 | WNS Holdings Ltdno ticker on file | — | 2.66% | $94.2M | 1.53M | $61.49 | 2 qtrs | No change |
| 11 | Arrivent Biopharma IncAVBP | — | 2.34% | $82.9M | 4.48M | $18.49 | 4+ qtrs | No change |
| 12 | Trip.com Group LtdTCOM · ADS | Consumer Discretionary | 1.69% | $59.7M | 938.84K | $63.58 | 4+ qtrs | ▲ Added 2.7% |
| 13 | Enfusion Incno ticker on file · CL A | — | 1.57% | $55.5M | 4.98M | $11.15 | 4+ qtrs | No change |
| 14 | Yatsen Holding LtdYSG · SPONSORED ADS | — | 0.94% | $33.1M | 6.89M | $4.81 | 4+ qtrs | No change |
| 15 | Cytek Biosciences IncCTKB | — | 0.75% | $26.7M | 6.66M | $4.01 | 4+ qtrs | No change |
| 16 | Baidu IncBIDU · SPON ADR REP A | Technology | 0.44% | $15.6M | 170K | $92.03 | 1 qtr | New |
| 17 | LI Auto IncLI · SPONSORED ADS | Consumer Discretionary | 0.44% | $15.6M | 620K | $25.20 | 1 qtr | New |
| 18 | Yum China Holdings IncYUMC | Consumer Discretionary | 0.43% | $15.2M | 292.12K | $52.06 | 1 qtr | New |
| 19 | Zto Express Cayman IncZTO · SPONSORED ADS A | Industrials | 0.38% | $13.3M | 671.39K | $19.84 | 4+ qtrs | ▲ Added 54% |
| 20 | Kanzhun LimitedBZ · SPONSORED ADS | Technology | 0.31% | $11M | 576.34K | $19.17 | 1 qtr | New |
| 21 | H World Group LtdHTHT · SPONSORED ADS | Consumer Discretionary | 0.25% | $8.8M | 237.33K | $37.01 | 1 qtr | New |
| 22 | Agora IncAPI · ADS | — | 0.24% | $8.4M | 2.1M | $4.02 | 2 qtrs | No change |
| 23 | Atour Lifestyle Holdings LtdATAT · SPONSORED ADS | Consumer Discretionary | 0.19% | $6.9M | 242.34K | $28.35 | 1 qtr | New |
| 24 | Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADS | Technology | 0.16% | $5.5M | 33K | $166.00 | 4+ qtrs | ▼ Reduced 23% |
| 25 | Gossamer Bio IncGOSS | — | 0.16% | $5.5M | 4.97M | $1.10 | 4+ qtrs | No change |
| 26 | Maze Therapeutics IncMAZE | — | 0.14% | $5M | 457.54K | $11.01 | 1 qtr | New |
| 27 | Novabridge BiosciencesNBP · SPONSORED ADS | — | 0.14% | $4.9M | 5.98M | $0.8239 | 4+ qtrs | No change |
| 28 | Tuya IncTUYA · SPONSERED ADS | — | 0.13% | $4.7M | 1.56M | $3.03 | 4+ qtrs | No change |
| 29 | Contineum Therapeutics IncCTNM · CL A | — | 0.13% | $4.7M | 669.34K | $6.98 | 4+ qtrs | No change |
| 30 | Smart SH Global Ltdno ticker on file · ADS | — | 0.13% | $4.4M | 3.95M | $1.12 | 4+ qtrs | No change |
| 31 | Sohu.com LtdSOHU · SPONSORED ADS | — | 0.08% | $2.7M | 201.43K | $13.17 | 4+ qtrs | ▼ Reduced 61% |
| 32 | Sagimet Biosciences IncSGMT | — | 0.07% | $2.4M | 724.8K | $3.26 | 4+ qtrs | No change |
| 33 | Mogu IncMOGU · SPON ADS | — | 0.05% | $1.9M | 847.51K | $2.21 | 4+ qtrs | No change |
| 34 | Bright Scholar ED Holdings Ltdno ticker on file · SPON ADS NEW | — | 0.05% | $1.7M | 988.14K | $1.67 | 4+ qtrs | No change |
| 35 | Danaher CorpDHR | Health Care | 0.05% | $1.6M | 8.03K | $205.00 | 4+ qtrs | ▼ Reduced 39% |
| 36 | JOYY IncJOYY · ADS REPSTG COM A | — | 0.04% | $1.4M | 34K | $41.98 | 3 qtrs | ▲ Added 13% |
| 37 | GE AerospaceGE | Industrials | 0.04% | $1.4M | 6.76K | $200.15 | 4+ qtrs | ▼ Reduced 35% |
| 38 | Moodys CorpMCO | Financials | 0.04% | $1.2M | 2.64K | $465.69 | 4+ qtrs | ▼ Reduced 41% |
| 39 | MSCI IncMSCI | Financials | 0.03% | $1.2M | 2.13K | $565.50 | 2 qtrs | ▼ Reduced 42% |
| 40 | China Yuchai International LtdCYD | — | 0.03% | $1.2M | 70K | $16.99 | 1 qtr | New |
| 41 | Pacific Biosciences of California IncPACB | — | 0.03% | $1.1M | 918.89K | $1.18 | 4+ qtrs | No change |
| 42 | Weibo CorpWB · SPONSORED ADR | — | 0.03% | $947K | 100K | $9.47 | 1 qtr | New |
| 43 | X FinancialXYF · SPONSORED ADS | — | 0.02% | $719.5K | 50K | $14.39 | 1 qtr | New |
| 44 | Aligos Therapeutics IncALGS | — | 0.02% | $629K | 76.25K | $8.25 | 4+ qtrs | No change |
| 45 | Ecarx Holdings IncECX · CLASS A ORD | — | 0.01% | $504K | 400K | $1.26 | 1 qtr | New |
| 46 | Metagenomi IncMGX | — | 0.01% | $205K | 150.7K | $1.36 | 4+ qtrs | ▼ Reduced 81% |
| 47 | Lakeshore Biopharma Co Ltdno ticker on file · ORD SHS NEW | — | 0.01% | $181.9K | 75.18K | $2.42 | 2 qtrs | No change |
| 48 | Uxin LtdUXIN · SPONSORED ADS | — | 0.00% | $76.4K | 19.16K | $3.99 | 4+ qtrs | No change |
| 49 | Ridgetech IncRDGT · SHS NEW | — | 0.00% | $21.2K | 20.17K | $1.05 | 4+ qtrs | No change |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Consumer Discretionary | 48.1% | $1.7B | 9 |
| Health Care | 13.7% | $486.2M | 3 |
| Financials | 12.5% | $443.3M | 3 |
| Technology | 8.67% | $306.8M | 4 |
| Real Estate | 6.80% | $240.5M | 1 |
| Industrials | 0.41% | $14.7M | 2 |
| No sector on file | 9.76% | $345.6M | 27 |
Questions and answers
What did Zhang Lei own in Q1 2025?
HHLR Advisors (Hillhouse)'s 13F for Q1 2025 lists 49 positions worth $3.5B. The largest: PDD (21.9%), BABA (14.6%), FUTU (12.5%), ONC (8.0%), NTES (7.8%).
What did Zhang Lei buy in Q1 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: PDD (added, $453.6M), FUTU (added, $326.4M), JD (added, $128.4M), BIDU (new, $15.6M), LI (new, $15.6M), YUMC (new, $15.2M).
What did Zhang Lei sell in Q1 2025?
The largest sales: ONC (reduced, $753.9M), BABA (reduced, $129.5M), VIPS (reduced, $128.5M), KNSA (sold out, $31.3M), BBIO (sold out, $28.1M), SOHU (reduced, $4.1M).
When was this filing made?
HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Mar 31, 2025 on May 15, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Zhang Lei portfolio, Q1 2025: HHLR Advisors (Hillhouse) 13F holdings”, data as of 15 May 2025. https://funkfolio.com/gurus/hillhouse/2025-q1
Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Mar 31, 2025.
Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Mar 31, 2025, filed May 15, 2025. Changes compare share counts with the filing for Dec 31, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $3.5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 4 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.